143 related articles for article (PubMed ID: 37594334)
1. Propranolol for the treatment of infantile hemangiomas: a nine-year monocentric experience from a tertiary hospital.
Volonté M; Codazzi AC; Davidovich S; Apicella A; Isoletta E; Barruscotti S; Massa M; Silvestri A; Marseglia GL; Brazzelli V
Eur J Dermatol; 2023 Jun; 33(3):265-269. PubMed ID: 37594334
[TBL] [Abstract][Full Text] [Related]
2. Treatment of problematic infantile hemangiomas with propranolol: a series of 40 cases and review of the literature.
Oksiuta M; Matuszczak E; Dębek W; Dzienis-Koronkiewicz E; Hermanowicz A; Tylicka M
Postepy Hig Med Dosw (Online); 2014 Sep; 68():1138-44. PubMed ID: 25228522
[TBL] [Abstract][Full Text] [Related]
3. Noninferiority and Safety of Nadolol vs Propranolol in Infants With Infantile Hemangioma: A Randomized Clinical Trial.
Pope E; Lara-Corrales I; Sibbald C; Liy-Wong C; Kanigsberg N; Drolet B; Ma J
JAMA Pediatr; 2022 Jan; 176(1):34-41. PubMed ID: 34747977
[TBL] [Abstract][Full Text] [Related]
4. Treatment with propranolol for infantile hemangiomas: single-center experience.
Turhan AB; Bör Ö; Özdemir ZC
J Cosmet Dermatol; 2016 Sep; 15(3):296-302. PubMed ID: 27061310
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the Clinical Outcomes of Parotid Hemangiomas in the Pediatric Patient Population.
Harris J; Phillips JD
Ear Nose Throat J; 2021 Jun; 100(5):NP242-NP245. PubMed ID: 31565986
[TBL] [Abstract][Full Text] [Related]
6. Propranolol for the treatment of orbital infantile hemangiomas.
Fridman G; Grieser E; Hill R; Khuddus N; Bersani T; Slonim C
Ophthalmic Plast Reconstr Surg; 2011; 27(3):190-4. PubMed ID: 21283032
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of propranolol cream in infantile hemangioma: A prospective pilot study.
Nagata E; Kashiwagura Y; Okada E; Tanaka S; Sano S; Nishida M; Hayano S; Iwashima S; Hakamata A; Odagiri K; Inui N; Watanabe H; Umemura K; Uchida S
J Pharmacol Sci; 2022 Jun; 149(2):60-65. PubMed ID: 35512856
[TBL] [Abstract][Full Text] [Related]
8. Quality of life improving after propranolol treatment in patients with Infantile Hemangiomas.
Pensabene M; Di Pace MR; Baldanza F; Grasso F; Patti M; Sergio M; La Placa S; Giuffre' M; Serra G; Casuccio A; Cimador M
Ital J Pediatr; 2022 Aug; 48(1):140. PubMed ID: 35927685
[TBL] [Abstract][Full Text] [Related]
9. Use of the Hemangioma Severity Scale to facilitate treatment decisions for infantile hemangiomas.
Moyakine AV; Herwegen B; van der Vleuten CJM
J Am Acad Dermatol; 2017 Nov; 77(5):868-873. PubMed ID: 28818436
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Propranolol vs Atenolol in Infants With Problematic Infantile Hemangiomas: A Randomized Clinical Trial.
Ji Y; Chen S; Yang K; Zhang X; Zhou J; Li L; Xiang B; Qiu T; Dai S; Jiang X; Lu G; Qiu L; Kong F; Zhang Y
JAMA Otolaryngol Head Neck Surg; 2021 Jul; 147(7):599-607. PubMed ID: 33856430
[TBL] [Abstract][Full Text] [Related]
11. Oral Nadolol for Children with Infantile Hemangiomas and Sleep Disturbances with Oral Propranolol.
Bernabeu-Wittel J; Narváez-Moreno B; de la Torre-García JM; Fernández-Pineda I; Domínguez-Cruz JJ; Coserría-Sánchez F; Álvarez-del-Vayo C; Conejo-Mir J
Pediatr Dermatol; 2015; 32(6):853-7. PubMed ID: 26447831
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of propranolol for cutaneous hemangiomas in premature children.
Brazzelli V; Giorgini C; Barruscotti S; Codazzi CA; Mannarino S; Tzialla C; Stronati M; Marseglia GL; Borroni G
G Ital Dermatol Venereol; 2016 Oct; 151(5):485-91. PubMed ID: 25692776
[TBL] [Abstract][Full Text] [Related]
13. Immediate possible adverse event rates in infants treated with oral propranolol for infantile haemangiomas at an Australian urban tertiary hospital between 2016 and 2019.
Adams L; Ryan E
Australas J Dermatol; 2022 Nov; 63(4):473-478. PubMed ID: 35938573
[TBL] [Abstract][Full Text] [Related]
14. Safety of propranolol for infantile hemangioma in infants less than five weeks corrected age.
Gatts JE; Rush MC; Check JF; Samelak DM; McLean TW
Pediatr Dermatol; 2022 May; 39(3):389-393. PubMed ID: 35243678
[TBL] [Abstract][Full Text] [Related]
15. Propranolol treatment of complicated hemangiomas.
Ozyörük D; Zengin E
Indian J Pediatr; 2014 Apr; 81(4):368-70. PubMed ID: 23832624
[TBL] [Abstract][Full Text] [Related]
16. Nd:YAG 1064-nm laser for residual infantile hemangioma after propranolol treatment.
Khamaysi Z; Pam N; Zaaroura H; Avitan-Hersh E
Sci Rep; 2023 May; 13(1):7474. PubMed ID: 37156812
[TBL] [Abstract][Full Text] [Related]
17. Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature.
Broeks IJ; Hermans DJ; Dassel AC; van der Vleuten CJ; van Beynum IM
Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1791-800. PubMed ID: 24074695
[TBL] [Abstract][Full Text] [Related]
18. Interventions for infantile haemangiomas of the skin.
Novoa M; Baselga E; Beltran S; Giraldo L; Shahbaz A; Pardo-Hernandez H; Arevalo-Rodriguez I
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD006545. PubMed ID: 29667726
[TBL] [Abstract][Full Text] [Related]
19. Management of infantile hemangiomas-experience of a tertiary hospital.
Gomes R; Salazar L; Fraga C; Correia MR; Barbosa-Sequeira J; Fernandes A; Álvares S; Banquart Leitão J; Paiva Coelho M
Eur J Pediatr; 2023 Apr; 182(4):1611-1618. PubMed ID: 36705724
[TBL] [Abstract][Full Text] [Related]
20. Treatment of infantile capillary hemangioma of the eyelid with systemic propranolol.
Vassallo P; Forte R; Di Mezza A; Magli A
Am J Ophthalmol; 2013 Jan; 155(1):165-170.e2. PubMed ID: 22967870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]